FORGOT YOUR DETAILS?

Past Summits

Consumer Med Summit 2009

Ritz Carlton/Laguna Niguel

April 22-23, 2009

Agenda

April 22, 2009+

6:00-8:00 pm
Registration, Cocktail and Dinner Reception

April 23, 2009+

7:30-8:45 am
Registration & Continental Breakfast
8:45-9:00 am
Welcome & Opening Remarks

Jim Glasheen

General Partner / Technology Partners

9:00-9:45 am
Transition from Pharma to Consumer

Dr. Mehmood Khan is the Chief Scientific Officer of PepsiCo. He is an Endocrinologist by training and most recently was the President of Takeda Pharmaceuticals R&D. Prior to Takeda, Dr. Khan was with the Mayo Clinic as the Director of the Diabetes, Endocrine and Nutrition Clinical Trials Unit in the division of Endocrinology. Dr. Khan will speak to his personal transition from focusing on a traditional pharmaceutical business to his far more consumer facing role now and what it means for Consumer Medicine in general.

Mehmood Khan, MD

SVP, Chief Scientific Officer / PepsiCo

Download Presentation
9:45-10:30 am
The Strategic Players Weigh In

Major pharmaceutical, medtech and consumer companies have been placing increasing emphasis on Consumer Medicine (CM), but what does it mean for the entrepreneurial community?

    How do strategic players view the CM landscape? What are the opportunities, what are the challenges?
    What lessons from major players should start-ups be integrating into their businesses?
    What are major companies seeking from the entrepreneurial community?
    What are the implications of a new administration?
    In the current economic environment, what areas within CM will flourish and which will flounder?
Moderator:

Steve Elms

Managing Director / Aisling Capital

Confirmed Panelists:

Joseph Modisett

Executive Director / Investment Banking Division
Morgan Stanley

Adele Gulfo

Vice President, Business Development / Innovation and Design-for-Launch
AstraZeneca Pharmaceuticals

Karl Ronn

Vice President- Research & Development Health Care & New Business / Procter & Gamble Company

10:30-11:15 am
Networking Reception
11:15-12:00 am
The Challenging Economy & a Shifting Healthcare Landscape:

What does it mean for Consumer Medicine?

    What are the implication of shifting site of care for healthcare product manufacturers (both Rx and OTC)
    How does health and wellness fit into consumer priorities during an economic downturn. Implications for HC product manufacturers?
    Does the shifting public policy environment have interesting implications for prevention products and services?
    Who is the “US Health Consumer” since it’s not homogenous and important that everyone understand the differences on attitudes, behaviors and unmet needs of the six discreet segments.
Paul H. Keckley, PhD

Executive Director / Deloitte Center for Health Solutions Deloitte LLP

Download Presentation
12:00-12:45 pm
The Serial Entrepreneur:

Looking Back, Looking Ahead
J. Andy Corley is corporate vice president and global president, Surgical Products, for Bausch & Lomb. In 1998, Andy co-founded eyeonics, Inc., which developed a new category of intraocular lens — the accommodating IOL — for use in cataract replacement surgery. He gained FDA approval for innovative crystalens® in 2003, and spearheaded a five-year effort to change CMS policy to allow Medicare beneficiaries to choose presbyopia-correcting IOLs. Eyeonics was acquired by Bausch & Lomb in 2008. Andy has held various executive positions at American Medical Optics and Allergan Pharmaceuticals. He was co-founder of Chiron Ophthalmics, where he played a key role in the introduction of LASIK surgery. Andy is a successful serial entrepreneur who brings a spirit of innovation to both product and organizational development

J. Andy Corley

Corporate Vice President & Global President, Surgical Products / Bausch & Lomb

Download Presentation
12:45-2:15 pm
Luncheon with Scott Gottlieb Top 10 List of Advice for the New Administration:

Dr. Gottlieb will discuss potential implications of the Administration’s stimulus and budget activities on the health care sector, with an emphasis on implications for innovation and product development in the consumer medicine space. He will discuss potential shifts in decision-making influence – and financial responsibility – among payers, prescribers, manufacturers, and patients as consumers.

Scott Gottlieb

Former Deputy Commissioner for Medical & Scientific Affairs / US Food and Drug Administration

2:15-3:00 pm
Putting the Platitudes to Work:

Lessons from the Front Lines
Translating high-level strategy into implementation can be particularly challenging in Consumer Medicine. Successful entrepreneurs discuss their experiences with specific advice as to how to get things done

    In building a team that balances consumer and healthcare experience
    In integrating consumer insight in to product development
    In working with the channel over time
Moderator:

Cami Samuels

Managing Director / Versant Ventures

Panelists:

Ernest Mario

CEO / Capnia

Eric Miller

President / Microfabrica Inc.

Jeff Nugent

President & CEO / Ventus Medical

Mike Valentino

Former CEO / Adams Respiratory/ Novartis

3:00-3:30 pm
Concept Testing…Insights Focus Groups Can’t Provide

How do you evaluate consumer receptiveness when bringing a wholly new product concept to market?

Mike Waite

Vice President, Enterprise Products and Marketing / MarketTools

3:30-4:15 pm
Networking Reception
4:15-5:00 pm
Emerging Influencers:

Who are the new players in the shifting Healthcare landscape and what does it mean for Consumer Medicine players?
In the healthcare landscape there are emerging and evolving influencers who have a fundamentally different relationship with patients and consumers. They also have a different set of objectives. What are the implications for Consumer Medicine?

    What problem is your company trying to solve and what is your company’s goal?
    What is the growth potential in your market? Why are new influencers emerging now and what are some potential trends?
    How can Consumer Medical product manufacturers effectively partner with the influencers?
    How is the partnership with influencers different from the traditional manufacturer-physician relationship or Direct-To-Consumer (DTC) marketing?
Moderator:

Ted Janus

Private Investors

Panelists:

Diane Miles

President & CEO / Perricone MD

Mark Murrison

Strategic Business Development / MDVIP

Kyle Rolfing

CEO / Redbrick Health

Vance Vanier

Chief Medical Officer / Navigenics

5:00-6:00 pm
The Innovator’s Prescription: A Disruptive Solution for Health Care

A prescription for what ails health care – how Disruptive Innovation will change the roles of providers and consumers in creating a more affordable, accessible and effective system for all.

Jason Hwang, MD, MBA

Executive Director, Healthcare / Innosight Institute

Download Presentation
6:00-6:10 pm
Wrap-Up
6:10-7:15 pm
Cocktail Reception
7:15-9:00 pm
Gala Dinner with America’s 1st Master Sommelier Eddie Osterland
9:00-11:00 pm
Casino Party

Speakers

J. Andy Corley Corporate Vice President & Global President Surgical Products Bausch & Lomb
Scott Gottlieb, MD Former Deputy Commissioner for Medical & Scientific Affairs US Food and Drug Administration
Adele Gulfo Vice President, Business Development, Innovation and Design-for-Launch AstraZeneca Pharmaceuticals LP
Jason Hwang Co-Founder & Executive Director of Healthcare Innosight Institute
Paul Keckley Executive Director, Center for Health Solutions Deloitte LLP
Mehmood Khan Senior Vice President and Chief Scientific Officer Pepsi Co.
Ernest Mario Chairman PPD Chairman & CEO Capnia
Diane Miles President and CEO Perricone MD
Eric Miller President Microfabrica Inc.
Joseph Modisett Executive Director Morgan Stanley | Investment Banking Division
Mark Murrison Strategic Business Development MDVIP
Jeffrey Nugent President and Chief Executive Officer Ventus Medical, Inc.
Kyle Rolfing CEO RedBrick Health
Karl Ronn Vice President-Research & Development,Health Care and New Business The Procter & Gamble Company
Michael J. Valentino Chairman of the Board, Plx Pharma Director Tria Beauty Company(former-CEO of Adam’s Respiratory Labs)
Vance Vanier Chief Medical Officer Navigenics
Mike Waite VP Enterprise Products & Marketing MarketTools